EUVIMEDEUVIMED entdecken
Crossref

Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2

Tristan W Dorey iD, Yingjie Liu iD, Hailey J Jansen iD, Loryn J Bohne iD, Martin Mackasey, Logan Atkinson, Shuvam Prasai iD, Darrell D Belke iD, Ali Fatehi-Hassanabad, Paul W M Fedak iD, Robert A Rose iD

Circulation: Arrhythmia and Electrophysiology · 2023

DOI: 10.1161/circep.123.012199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2023. Verfasst von Tristan W Dorey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Sciences (T.W.D., Y.L., H.J.J., L.J.B., M.M., S.P., D.D.B, A.F.-H., P.W.M.F., R.A.R.), Libin Cardiovascular Institute, Cumming …. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: β-AR (β-adrenergic receptor) stimulation regulates atrial electrophysiology and Ca 2+ homeostasis via cAMP-dependent mechanisms; however, enhanced β-AR signaling can promote atrial fibrillation (AF). CNP (C-type natriuretic peptide) can also regulate atrial electrophysiology through the activation of NPR-B (natriuretic peptide receptor B) and cGMP-dependent signaling. Nevertheless, the role of NPR-B in regulating atrial electrophysiology, Ca 2+ homeostasis, and atrial arrhythmogenesis is incompletely understood. METHODS: Studies were performed using atrial samples from human patients with AF or sinus rhythm and in wild-type and NPR-B-deficient (NPR-B +/− ) mice. Studies were conducted in anesthetized mice by intracardiac electrophysiology, in isolated mouse atrial preparations using high-resolution optical mapping, in isolated mouse and human atrial myocytes using patch-clamping and Ca 2+ imaging, and in mouse and human atrial tissues using molecular biology. RESULTS: Atrial NPR-B protein levels were reduced in patients with AF, and NPR-B +/− mice were more susceptible to AF. Atrial cGMP levels and PDE2 (phosphodiesterase 2) activity were reduced in NPR-B +/− mice leading to larger increases in atrial cAMP in the presence of the β-AR agonist isoproterenol. NPR-B +/− mice displayed larger increases in action potential duration and L-type Ca 2+ current in the presence of isoproterenol. This resulted in the occurrence of spontaneous sarcoplasmic reticulum Ca 2+ release events and delayed afterdepolarizations in NPR-B +/− atrial myocytes. Phosphorylation of the RyR2 (ryanodine receptor) and phospholamban was increased in NPR-B +/− atria in the presence of isoproterenol compared with the wildtypes. C-type natriuretic peptide inhibited isoproterenol-stimulated L-type Ca 2+ current through PDE2 in mouse and human atrial myocytes. CONCLUSIONS: NPR-B protects against AF by preventing enhanced atrial responses to β-adrenergic receptor agonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHumansMiceAnimalsIsoproterenolNatriuretic Peptide, C-TypeHeart AtriaMyocytes, Cardiac

Stichwörter der Autor:innen

atrial fibrillationbeta adrenergic receptorscyclic nucleotidesion channelsnatriuretic peptides

Substanzen

IsoproterenolNatriuretic Peptide, C-Type

Autor:innen und Institutionen

  • Department of Cardiac Sciences (T.W.D., Y.L., H.J.J., L.J.B., M.M., S.P., D.D.B, A.F.-H., P.W.M.F., R.A.R.), Libin Cardiovascular Institute, Cumming School of Medicine University of Calgary, Alberta, Canada.
  • Department of Physiology and Pharmacology (T.W.D., Y.L., H.J.J., L.J.B., M.M., S.P., R.A.R.), Libin Cardiovascular Institute, Cumming School of Medicine University of Calgary, Alberta, Canada.
  • Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada (L.A.).

ORCID-Profile: Tristan W Dorey, Yingjie Liu, Hailey J Jansen, Loryn J Bohne, Shuvam Prasai, Darrell D Belke, Paul W M Fedak, Robert A Rose

Zitieren

APA

Dorey, T. W., Liu, Y., Jansen, H. J., Bohne, L. J., Mackasey, M., Atkinson, L., Prasai, S., Belke, D. D., Fatehi-Hassanabad, A., Fedak, P. W. M., & Rose, R. A. (2023). Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.123.012199

Vancouver

Dorey TW, Liu Y, Jansen HJ, Bohne LJ, Mackasey M, Atkinson L, et al. Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2. Circulation: Arrhythmia and Electrophysiology. 2023. doi:10.1161/circep.123.012199

BibTeX
@article{Dorey2023,
  author = {Dorey, Tristan W and Liu, Yingjie and Jansen, Hailey J and Bohne, Loryn J and Mackasey, Martin and Atkinson, Logan and Prasai, Shuvam and Belke, Darrell D and Fatehi-Hassanabad, Ali and Fedak, Paul W M and Rose, Robert A},
  title = {Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2023},
  doi = {10.1161/circep.123.012199}
}
Kostenlos starten →